Trials / Not Yet Recruiting
Not Yet RecruitingNCT07442071
Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome
Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome: A Multicenter Randomized and Double-blind Trial.
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 4,336 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will test whether a lower dose of epinephrine (0.5 mg) given during emergency treatment for out-of-hospital cardiac arrest helps more patients survive with good brain function, compared to the standard dose (1 mg). Adults who experience cardiac arrest outside the hospital and are treated by emergency medical teams will be randomly assigned to receive either the low dose or the standard dose of epinephrine. The study will compare survival and neurological outcomes between the two groups over 28 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epinephrine 0.5 mg intravenous bolus | Epinephrine 0.5 mg/mL solution for injection, administered as a 0.5 mg intravenous bolus every 3 to 5 minutes during cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest. T |
| DRUG | Epinephrine 1 mg intravenous bolus | Epinephrine 1 mg/mL solution for injection, administered as a 1 mg intravenous bolus every 3 to 5 minutes during cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest. |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2030-07-01
- Completion
- 2030-07-01
- First posted
- 2026-03-02
- Last updated
- 2026-03-02
Locations
26 sites across 1 country: France
Source: ClinicalTrials.gov record NCT07442071. Inclusion in this directory is not an endorsement.